By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


Company News
Akebia (AKBA) Spinoff Aerpio Scores $40 Million 3/16/2017 6:33:20 AM
Akebia (AKBA) Announces Fourth Quarter And Full-Year 2016 Financial Results 3/7/2017 8:46:46 AM
Akebia (AKBA) To Host Conference Call On March 6th To Discuss Full-Year 2016 Financial Results And Corporate Highlights 3/1/2017 8:30:56 AM
Akebia (AKBA) Licenses Portfolio Of Novel HIF Compounds From Johnson & Johnson Innovation (JNJ) 2/13/2017 6:23:54 AM
Akebia (AKBA) Forges $1B U.S. Deal with Otsuka Pharma on Late-Stage Drug 12/20/2016 6:44:47 AM
Akebia (AKBA) Prevails in Additional European Patent Dispute 12/12/2016 10:31:47 AM
Akebia (AKBA) Announces Third Quarter 2016 Financial Results 11/10/2016 3:11:32 PM
Akebia (AKBA) Announces Publication Highlighting Potential Benefits Of HIF Treatments For Patients With Renal Anemia 9/26/2016 10:50:16 AM
Akebia (AKBA) Announces Publication Of Phase IIb Data For Vadadustat In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease 9/19/2016 11:18:35 AM
Akebia (AKBA) To Present At Upcoming Investor Conferences 9/7/2016 12:56:51 PM